Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
03/1999
03/31/1999EP0904093A1 Administration of polypeptide growth factors following central nervous system ischemia or trauma
03/31/1999EP0904087A1 Phosphatidic acid-comprising compositions
03/31/1999EP0904085A1 USE OF ESTROGEN TO MODIFY THE AMOUNT OF SEROTONIN TRANSPORTER OR ITS mRNA
03/31/1999EP0904081A1 Aqueous suspensions of 9-hydroxyrisperidone fatty acid esters
03/31/1999EP0904073A1 Zwitterionic compositions and methods as biological response modifiers
03/31/1999EP0750507A4 PROTEASOME REGULATION OF NF--g(k)B ACTIVITY
03/31/1999EP0714395B1 Vasoconstrictive substituted dihydropyranopyridines
03/31/1999CN1212698A Morphine and diamorphine salts of anionic non-narcotic analgesics of substituted carboxylic acid type
03/31/1999CN1212692A Substituted A2a-and diazacycloheptane and cyclooctane compounds and their use
03/31/1999CN1212691A Tricyclic compound and its preparation and use
03/31/1999CN1212690A Novel piperidines derived from 1-(piperazin-1-yl) aryl (oxylamino) carbonyl/4-aryl-piperidine as selective 5-HTiD beta receptor antagonist
03/31/1999CN1212689A Novel aryl glycinamide derivatives, method of producing said derivatives and pharmaceutical compositions containing these compounds
03/31/1999CN1212682A Aminotetralin derivatives and composition and method of use thereof
03/31/1999CN1212627A Method for treating insomnia
03/31/1999CN1212620A Mercapto derivatives as inhibitors of cyclooxygenases
03/31/1999CN1212149A Use of inhibitor of Na+/H+ exchanger for production of medicament
03/31/1999CN1042730C Method for preparing pyrazolopyridine compound
03/30/1999US5889173 DNA encoding multifunctional neurothrophic factors
03/30/1999US5889042 Method of treating diseases and conditions with estrogen agonists and antagonists
03/30/1999US5889035 1-(Arylthioalkyl, arylaminoalkyl or arylmethylenealkyl)-3-(heteroaryl) pyrrolidines and related compounds useful as antipsychotics and analgesics
03/30/1999US5889033 Famotidine a histamine h2-antagonist is used to amelilorate apathy-amotivation syndrome and second set of psychologiacal disorders treating agents are psychostimulants, muscarinic agents, acetyl-cholinesterase inhibitors and notropics
03/30/1999US5889026 N-methyl-d-asparatate-receptor subtype selective blocker
03/30/1999US5889022 Psychological disorders
03/30/1999US5889020 Treatment of normotensive glaucoma with angiotensin II antagonists
03/30/1999US5889018 Heterocyclic compounds, pharmaceutical compositions comprising them and process for the preparation thereof
03/30/1999US5889008 Substituted 1-indolylpropyl-4-phenethylpiperazadine derivatives
03/30/1999US5889006 Muscarinic antagonists
03/30/1999US5889004 4-heteroaryl-1-piperazinealkylthiols and derivatives thereof and their therapeutic utility
03/30/1999US5889002 Fused 1,2,4-thiadiazine and fused 1,4-thiazine derivatives, their preparation and use
03/30/1999US5888999 Using azacyclic and azabicyclic pyrazine compounds
03/30/1999US5888770 Spoiiie
03/30/1999US5888542 Matrix tablet allowing the prolonged release of the sodium salt of tianeptine after administration by the oral route
03/30/1999US5888536 Alzheimer*s disease; parkinson*s disease; psychological disorders
03/30/1999US5888494 Topical
03/30/1999CA2085975C Dentinal desensitizing compositions
03/25/1999WO1999014346A2 SENSE mRNA THERAPY
03/25/1999WO1999014328A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/25/1999WO1999014213A1 Substituted chroman derivatives
03/25/1999WO1999014212A1 Substituted chroman derivatives
03/25/1999WO1999014207A1 Substituted indan derivatives
03/25/1999WO1999014199A1 Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocine-10-oles, method for the production and use thereof as medicaments
03/25/1999WO1999014197A1 Substituted isoquinolines as anticonvulsivants
03/25/1999WO1999014195A1 2-aminopyridines as inhibitors of cyclooxygenase-2
03/25/1999WO1999013911A1 Nootropic agent
03/25/1999WO1999013908A1 Compound inhibiting presenilin 1 for preparing a medicine and a diagnostic agent
03/25/1999WO1999013878A1 A COMBINATION OF A MONOAMINE OXIDASE INHIBITOR AND A h5-HT1B ANTAGONIST OR PARTIAL AGONIST
03/25/1999WO1999013877A1 A COMBINATION OF A 5-HT REUPTAKE INHIBITOR AND A h5-HT1B ANTAGONIST OR PARTIAL AGONIST
03/25/1999WO1999013876A1 A COMBINATION OF A SELECTIVE 5-HT1A ANTAGONIST AND A SELECTIVE h5-HT1B ANTAGONIST OR PARTIAL AGONIST
03/25/1999WO1999013799A1 Synergistic analgesic combination of opioid analgesic and cyclooxygenase-2 inhibitor
03/25/1999WO1999013717A1 A delivery of arginine to cause beneficial effects
03/25/1999WO1999003822A8 Bicyclic metabotropic glutamate receptor ligands
03/25/1999WO1998051665A3 Novel macrocyclic compounds as metalloprotease inhibitors
03/25/1999CA2382376A1 Novel polypeptides and nucleic acids encoding pro287 which are useful for treating disorders of the pancreas
03/25/1999CA2304982A1 Sense mrna therapy
03/25/1999CA2304037A1 Substituted chroman derivatives
03/25/1999CA2304011A1 Compound inhibiting presenilin 1 for preparing a medicine and a diagnostic agent
03/25/1999CA2303926A1 Substituted chroman derivatives
03/25/1999CA2303839A1 Substituted indan derivatives
03/25/1999CA2303834A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/25/1999CA2303777A1 Substituted isoquinolines as anticonvulsivants
03/25/1999CA2302383A1 A combination of a selective 5-ht1a antagonist and a selective h5-ht1b antagonist or partial agonist
03/25/1999CA2302382A1 A combination of a 5-ht reuptake inhibitor and a h5-ht1b antagonist or partial agonist
03/25/1999CA2302204A1 A combination of a monoamine oxidase inhibitor and a h5-ht1b antagonist or partial agonist
03/25/1999CA2301782A1 Nootropic agent
03/25/1999CA2244978A1 Novel alcohol dehydrogenase
03/25/1999CA2244971A1 Mure
03/24/1999EP0903353A1 Imidazolidine derivates, their preparation and use, and pharmaceutical compositions containing them
03/24/1999EP0903345A1 Crystal form of N-(4-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamid
03/24/1999EP0903146A1 21-Hydroy-6,19-oxidoprogesterone (210h-60p) as antiglucocorticoid
03/24/1999EP0902837A1 Tailless nuclear hormone receptor (tlx receptor)
03/24/1999EP0902684A1 Hexahydro-pyrido(4,3-b)indole derivatives as antipsychotic drugs
03/24/1999EP0716650B1 Indole and indoline derivatives as 5ht1d receptor antagonists
03/24/1999EP0667855B1 Substituted arylalkynyl- and heteroarylalkynyl-n-hydroxyurea inhibitors of leukotriene biosynthesis
03/24/1999EP0640085B1 Fused imidazole and triazole derivatives as 5-ht1 receptor agonists
03/24/1999EP0563128B1 New 3,4-dihydroisoquinoline derivates and new pharmaceutical use of carbocyclically and heterocyclically annulated dihydropyridines
03/24/1999CN1211990A Isoquinolines useful as analgesics
03/24/1999CN1211983A Azabicyclic esters of carbamic acids useful in therapy
03/24/1999CN1211982A Tropane derivatives, their preparation and use
03/24/1999CN1211981A Oxa-and thia-diazole muscarinic receptor antagonists
03/24/1999CN1211974A Quinoline-2-(1H)-ones
03/24/1999CA2247733A1 The use of an inhibitor of the na+/h+ exchanger for the production of a medicament for the treatment or prophylaxis of disturbances of the central nervous system
03/23/1999US5886178 3-aroylbenzylpyridazinone derivatives
03/23/1999US5886039 Administering to uretha a lipophilic active agent selected from the group consisting of vasoactive prostaglandins
03/23/1999US5886028 Method for the inhibition of ALDH-I useful in the treatment of alcohol dependence or alcohol abuse
03/23/1999US5886023 N-(2,6-dimethylphenyl)-2-(2-oxo-1-pyrrolidino)acetamide; alzheimer's disease; cerebrovascular dementia; pschological disorders
03/23/1999US5886020 3-(4'-dimethylaminobenzylidenyl)-2-indolinone and analogues thereof for the treatment of disease
03/23/1999US5886009 Quinuclidine derivative as a substance P antagonist
03/23/1999US5886008 5-arylindole derivatives
03/23/1999US5886004 Tetrahydrobetacarboline compounds
03/23/1999US5886001 Agonist compounds
03/23/1999US5885988 Benzo g!quinoline derivatives
03/23/1999US5885986 Cleaving, n-alkylating and reducing the intermediate formed by reacting an oxazolyl and thiazolylimidazobenzo and thienodiazepine derivatives with amine compounds; used as anxiolytic and anticonvulsant or sedative-hypnotic agents
03/23/1999US5885959 Cyclic peptide compounds and their production process
03/23/1999US5885800 DNA encoding tumor necrosis related receptor, TR4
03/23/1999US5885572 Administering polypeptide or active fragment to treat bacterial infections
03/23/1999CA2247735A1 Novel 5-membered ring heterocycles, their preparation, their use and pharmaceutical preparations comprising them
03/23/1999CA2120028C Indol derivatives for the treatment of migrane
03/23/1999CA2092794C Naphthylalkylamines, process for their preparation and pharmaceutical compositions that contain them
03/23/1999CA2072624C Treatment of obesity with an alpha-2-adrenergic agonist and a growth hormone releasing peptide
03/23/1999CA2016181C Arylthiazolylimidazoles as 5ht3 antagonists
1 ... 1560 1561 1562 1563 1564 1565 1566 1567 1568 1569 1570 1571 1572 1573 1574 1575 1576 1577 1578 1579 1580 ... 1833